Adaptimmune Therapeutics Plc (ADAPY)
0.0384
0.00 (0.00%)
USD |
OTCM |
Dec 18, 16:00
Adaptimmune Therapeutics Shareholders Equity (Annual): 11.85M for Dec. 31, 2024
Shareholders Equity (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Annual) Benchmarks
| Biodexa Pharmaceuticals Plc | 10.42M |
| NuCana Plc | 7.457M |
| Autolus Therapeutics Plc | 427.32M |
| Mereo BioPharma Group Plc | 60.97M |
| Bicycle Therapeutics Plc | 793.06M |